Biocon signs commercialisation pact with Juno Pharma in Canada for Liraglutide
Liraglutide is a drug-device combination for the treatment and management of Type 2 diabetes and obesity
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.